Page 526 - IJB-9-6
P. 526

International Journal of Bioprinting                         Advances for 3D-printed oral drug delivery systems




            Funding                                            4.   Senapati S, Mahanta A, Kumar S, et al., 2018, Controlled
                                                                  drug delivery vehicles for  cancer treatment and their
            The authors acknowledge the institutional funding     performance. Sig Transduct Target Ther, 3 (1): 7.
            received from Tecnologico de Monterrey and the National
            Council of Humanities, Science and Technology of Mexico   https://doi.org/10.1038/s41392-017-0004-3
            (CONAHCYT) through Graduate Studies Scholarships   5.   Mei Y, He C, Gao C, et al., 2021, 3D-printed degradable anti-
            and Academic Scholarships provided by CONAHCYT as     tumor scaffolds for controllable drug delivery. Int J Bioprint,
            members of the National System of Researchers (Sistema   7(4): 418.
            Nacional de Investigadores).                          https://doi.org/10.18063/ijb.v7i4.418
                                                               6.   Zheng C, Attarilar S, Li K, et al., 2021, 3D-printed HA15-
            Conflict of interest                                  loaded β-tricalcium phosphate/poly (lactic-co-glycolic acid)
            The authors declare no conflicts of interests.        bone tissue scaffold promotes bone regeneration in rabbit
                                                                  radial defects. Int J Bioprint, 7(1): 317.
            Author contributions                                  https://doi.org/10.18063/ijb.v7i1.317
            Conceptualization:  Veronica L. Rios-Mata,  Marisela   7.   Kanaki Z, Chandrinou C, Orfanou IM, et al., 2022, Laser-
               Rodriguez-Salvador, Pedro F. Castillo-Valdez       induced forward transfer printing on microneedles for
            Formal analysis: Veronica L. Rios-Mata                transdermal delivery of gemcitabine. Int J Bioprint, 8(2): 554.
            Investigation: Veronica L. Rios-Mata, Pedro F. Castillo-Valdez  https://doi.org/10.18063/ijb.v8i2.554
            Methodology: Veronica L. Rios-Mata, Marisela Rodriguez-  8.   Euromonitor International, 2022, Global overview of the
               Salvador                                           pharmaceuticals and medical equipment industry, viewed
            Writing – original draft: Veronica L. Rios-Mata       April 18, 2023,
            Writing – review & editing: Marisela Rodriguez-Salvador,   https://www.portal.euromonitor.com/Analysis/Tab#
               Pedro F. Castillo-Valdez, Jia An, Chee Kai Chua
                                                               9.   What are the Benefits of Direct Compression in Tablets?,
            Ethics approval and consent to participate            2022, viewed July 12, 2023,
                                                                  https://www.fette-compacting-parts.com/blog/direct-
            Not applicable.
                                                                  compression-benefits-tablets/
            Consent for publication                            10.  Zuccari G, Alfei S, Marimpietri D, et al., 2022, Mini-tablets:
                                                                  A valid strategy to combine efficacy and safety in pediatrics.
            Not applicable.                                       Pharmaceutics, 15(1): 108.
            Availability of data                                  https://doi.org/10.3390/ph15010108
                                                               11.  Rana A, Hari Kumar S, 2013, Manufacturing defects of
            Not applicable.                                       tablets - A review. JDDT, 3(6): 200–206.
                                                                  https://doi.org/10.22270/jddt.v3i6.722
            References
                                                               12.  Ventola CL, 2014, Medical applications for 3D printing:
            1.   Gao  J, Karp J,  Langer  R,  et al.,  2023, The future  of  drug   Current and projected uses. P T, 39(10): 704–711.
               delivery. Chem Mater, 35(2), 359–363.           13.  Kozakiewicz-Latała  M,  Nartowski  KP,  Dominik  A,  et al.,
               https://doi.org/10.1021/acs.chemmater.2c03003      2022, Binder jetting 3D printing of challenging medicines:
                                                                  From low dose  tablets to hydrophobic molecules.  Eur J
            2.  National  Institute  of  Biomedical  Imaging  and  Pharm Biopharm, 170(2022): 144–159.
               Bioengineering, 2022, Drug delivery systems, viewed April
               19, 2023,                                          https://doi.org/10.1016/j.ejpb.2021.11.001
               https://www.nibib.nih.gov/science-education/science-  14.  Mancilla-De-la-Cruz J, Rodriguez-Salvador M, An J, et al.,
               topics/drug-delivery-systems-getting-drugs-their-targets-  2022, Three-dimensional printing technologies for drug
               controlled-manner#:~:text=for%20drug%20delivery%3F-  delivery applications: Processes, materials, and effects. Int J
               ,What%20are%20drug%20delivery%20systems%3F,a%20    Bioprinting, 8(4), 321–346.
               vaccine%20that%20is%20injected                     https://0-doi-org.biblioteca-ils.tec.mx/10.18063/ijb.v8i4.622
            3.   Kim J, Jesus O, 2023, Medication routes of administration.   15.  Chen G, Xu Y, Kwok P,  et al., 2020, Pharmaceutical
               StatPearls Publishing, viewed April 19, 2023,      applications of 3D printing. Addit Manuf, 34(2020): 101209.
               https://www.ncbi.nlm.nih.gov/books/NBK568677/      https://doi.org/10.1016/j.addma.2020.101209



            Volume 9 Issue 6 (2023)                        518                          https://doi.org/10.36922/ijb.1119
   521   522   523   524   525   526   527   528   529   530   531